HCP Education - Teva
HCP Education - Teva supports healthcare professionals, patients, and caregivers through independent education to strengthen clinical decisions and improve health behaviors or health status.
Funder: Teva
Due Dates: At least 60 days before the event or required decision date, whichever is earlier
Funding Amounts: Award amounts and duration not specified
Summary: Supports independent education that strengthens healthcare professionals’ knowledge, competence, and clinical decisions in neurological and psychiatric conditions and biosimilars.
Key Information: Contact with Teva employees outside the U.S. Medical Education Department about pending or future requests may result in denial.
Description
Teva’s HCP Education program supports innovative, high-quality independent medical education and patient education. It emphasizes evidence-based, clinically relevant, performance-based learning that strengthens healthcare professionals’ knowledge, competence, and clinical decision-making. Patient education initiatives help professionals and others communicate information that improves patients’ and caregivers’ health behaviors or health status.
Current education objectives cover Huntington’s disease, tardive dyskinesia, schizophrenia, Tourette syndrome, and biosimilars. Across these areas, priorities include recognition and diagnosis, disease burden, treatment options, unmet needs, and effective management. Teva considers accredited and non-accredited professional education, including symposia and web activities, with higher priority for accredited programs. Programs with multiple supporters are preferred, and fellowships are considered case by case.
